Introduction {#sec1}
============

Stroke is the second leading cause of long-term disability and is the second leading cause of death worldwide. The incidence of stroke can be reduced by elimination of risk factors in the healthy population (such as smoking, obesity, inactivity, unhealthy diets, and excessive alcohol intake) and by treatment of known risk factors for stroke (hypertension, diabetes, heart disease, lipid and coagulation disorders, inflammation). Diabetes prevalence is estimated between 15% and 25% of patients with ischemic stroke \[[@cit0001]--[@cit0004]\], but undiagnosed diabetes and impaired glucose tolerance account for 5--28% \[[@cit0005]\]. Diabetes is associated with an increased risk of ischemic stroke, and it also changes its clinical picture and affects the outcome \[[@cit0006]\]. Hyperglycemia is common during the acute period of stroke and can occur in patients with or without diabetes \[[@cit0003], [@cit0007]\]. Hyperglycemia is an independent risk factor for poor clinical outcome \[[@cit0003], [@cit0005], [@cit0008]--[@cit0011]\]. Hyperglycemia occurs in 30--40% of patients with acute ischemic stroke \[[@cit0005], [@cit0012], [@cit0013]\] and 43--59% of hemorrhagic stroke patients \[[@cit0014]\]. According to the literature, there is a lack of clear data that diabetes is a risk of in-hospital death.

The aim of this study was to investigate the impact of hyperglycemia and diabetes on in-hospital death amongst ischemic and hemorrhagic stroke patients. Furthermore, we evaluated selected risk factors affecting hospital events, in-hospital outcome and the length of hospitalization of patients with ischemic and hemorrhagic stroke.

Material and methods {#sec2}
====================

We analyzed 766 consecutive patients with ischemic and hemorrhagic stroke who were admitted to the Department of Neurology, Medical University Hospital (Bialystok, Poland). Stroke was diagnosed based on neurological examination and admission computed tomography scan. Patients with subarachnoid hemorrhage, transient ischemic attacks, after loss of consciousness, brain tumor, head trauma and patients with incomplete data were excluded. No patient underwent thrombolysis. Patients were classified into four groups: patients with ischemic stroke and diabetes, patients with ischemic stroke and without diabetes, patients with hemorrhagic stroke and diabetes, and patients with hemorrhagic stroke and without diabetes.

Clinical variables {#sec2.1}
------------------

At admission demographic data (age, gender), metabolic parameters (serum glucose, creatinine, cholesterol) were recorded. At admission venous plasma glucose level was measured in the emergency room. All patients underwent brain computed tomography at admission. Hypertension, coronary heart disease, history of myocardial infarction, atrial fibrillation, and history of previous stroke were recorded. Diabetes was defined if the patient had a history of diabetes that was confirmed by their medical records or was using oral hypoglycemic treatment or insulin. The length of hospitalization was also recorded.

The study protocol was approved by the local Medical University Ethics Committee. All patients were fully informed about the study and gave their consent.

Results {#sec3}
=======

We collected data from 766 patients with stroke (83.15% with ischemic and 16.84% with hemorrhagic stroke). The mean age of the study population was 70.90 ±12.52 years. Patients with ischemic stroke were significant older compared to hemorrhagic stroke patients (72.14 ±11.38; 64.80 ±15.76 years respectively; *p* \< 0.001). The mean age of patients with ischemic stroke with and without diabetes was similar. The mean age of patients with hemorrhagic stroke and diabetes was 73.17 (non-significant -- NS), and without diabetes 63.9 (*p* = 0.054) ([Table I](#t0001){ref-type="table"}). Previous diagnosis of diabetes was established in 21.5% of patients with ischemic and 9.3% with hemorrhagic stroke (*p* = 0.001). A total of 668 (87.3%) patients had hypertension, comparable in both types of stroke (87.6% vs. 86.0%; NS). Hypertension occurred more frequently in patients with ischemic stroke and diabetes, compared to patients without diabetes (86.1 vs. 92.7%. respectively *p* = 0.041). At admission cholesterol and low-density lipoprotein (LDL) cholesterol levels in non-diabetic patients were significantly higher than diabetics. High-density lipoprotein (HDL) cholesterol levels were lower in patients with diabetes. At admission amongst patients with ischemic stroke and diabetes the mean serum creatinine was significantly higher compared to non-diabetic patients (1.35 ±1.28 mg/dl vs. 1.07 ±0.60 mg/dl, *p* \< 0.000). Fibrinogen levels at admission were higher in diabetic patients. 32.2% of patients with ischemic and 15.5% of patients with hemorrhagic stroke had a history of previous stroke. A history of concomitant coronary heart disease/myocardial infarction occurred more frequently in patients with diabetes ([Table II](#t0002){ref-type="table"}).

###### 

Basal clinical characteristics of the studied population in relation to age and gender

  Parameter                     Non-diabetic   Diabetic       Total   *P*-value                            
  --------------------- ------- -------------- -------------- ------- -------------- ------ -------------- -------
  Age:                                                                                                     
   Hemorrhagic stroke           499            71.92 ±11.90   137     72.90 ±9.28    636    72.13 ±11.38   NS
   Ischemic stroke              117            63.94 ±16.01   12      73.17 ±10.19   129    64.80 ±15.76   0.054
  Gender:                                                                                                  
   Ischemic stroke      Males   264            52.9           68      49.6           332    52.2           0.501
  Females               235     47.1           69             50.4    304            47.8                  
   Hemorrhagic stroke   Males   53             45.3           7       58.3           60     46.5           0.545
  Females               64      54.7           5              41.7    69             53.5                  

###### 

Clinical characteristics of the population studied at admission to hospital

  Parameter                                                   Non-diabetic   Diabetic         Total          *P*-value                                        
  ------------------------------------------------ ---------- -------------- ---------------- -------------- ---------------- -------------- ---------------- --------------
  Hypertension:                                                                                                                                               
   Ischemic stroke                                            429            86.1             127            92.7             556            87.6             **0.041**
   Hemorrhagic stroke                                         99             84.6             12             100.0            111            86.0             0.215
  Blood pressure at admission \[mm Hg\]:                                                                                                                      
   Ischemic stroke                                 Systolic   499            152.67 ±25.10    137            156.99 ±23.53    636            153.60 ±24.82    NS
  Diastolic                                        499        88.20 ±12.49   137              88.90 ±12.59   636              88.35 ±12.50   NS               
   Hemorrhagic stroke                              Systolic   117            164.53 ±36.14    12             164.17 ±33.43    129            164.50 ±35.77    NS
  Diastolic                                        117        93.50 ±16.23   12               94.17 ±16.21   129              93.57 ±16.17   NS               
  Cholesterol \[mg/dl\]:                                                                                                                                      
   Ischemic stroke                                            406            184.36 ±40.97    107            168.83 ±42.30    513            181.12 ±41.69    **\< 0.001**
   Hemorrhagic stroke                                         48             183.42 ±50.83    9              194.00 ±50.18    57             185.09 ±50.43    0.555
  HDL \[mg/dl\]:                                                                                                                                              
   Ischemic stroke                                            398            50.50 ±56.80     106            36.61 ±13.89     504            47.58 ±51.17     **\< 0.001**
   Hemorrhagic stroke                                         46             45.23 ±17.43     9              43.84 ±14.71     55             45.01 ±16.89     1.000
  LDL \[mg/dl\]:                                                                                                                                              
   Ischemic stroke                                            398            118.37 ±35.93    106            109.30 ±32.35    505            116.50 ±35.38    **0.025**
   Hemorrhagic stroke                                         46             116.09 ±42.94    9              131.33 ±42.95    55             118.58 ±42.92    0.290
  Creatinine at admission \[mg/dl\]:                                                                                                                          
   Ischemic stroke                                            451            1.08 ±0.51       118            1.38 ±1.33       569            1.14 ±0.77       **\< 0.001**
   Hemorrhagic stroke                                         95             1.04 ±0.92       11             1.02 ±0.27       106            1.04 ±0.87       0.171
  Fibrinogen at admission \[mg/dl\]:                                                                                                                          
   Ischemic stroke                                            419            403.48 ±113.62   109            440.09 ±145.33   528            411.04 ±121.60   **0.004**
   Hemorrhagic stroke                                         98             413.55 ±147.00   11             517.12 ±144.80   109            424.00 ±149.44   **0.009**
  Prior stroke:                                                                                                                                               
   Ischemic stroke                                            157            31.8             47             34.3             204            32.3             0.606
   Hemorrhagic stroke                                         16             13.7             4              33.3             20             15.5             0.091
  Coronary artery disease/myocardial infarction:                                                                                                              
   Ischemic stroke                                            208            41.8             71             51.8             279            43.9             0.041
   Hemorrhagic stroke                                         21             17.9             5              41.7             26             20.2             0.065

Mean admission glucose was 123.80 ±58.10 mg/dl (124.31 ±60.71 mg/dl in ischemic and 121.36 ±43.56 mg/dl (NS) in hemorrhagic stroke patients). Mean admission glucose in all patients who died was significantly higher than in patients who survived. Amongst diabetic patients glucose levels were significantly higher than in non-diabetic patients ([Table III](#t0003){ref-type="table"}). At admission blood samples for glycated hemoglobin (HbA~1c~) were drawn for 122 (15.94%) patients. The mean HbA~1c~ in patients with ischemic stroke and without diabetes was 5.70 ±0.45% and in those with diabetes was 7.25 ±1.44%, and amongst patients with hemorrhagic stroke it was 5.78 ±0.40 vs. 5.90 ±0.00%, respectively. Insulin has been used in the treatment of patients with ischemic stroke and diabetes in 30.7% (*p* \< 0.01), and hemorrhagic stroke patients in 66.7% (*p* \< 0.01). In-hospital mortality in patients with ischemic stroke was 13.1% (non-diabetic 13.6%. and diabetic 10.9%, NS) and with hemorrhagic stroke was 24.0% (non-diabetic 21.4%, diabetic 50.0%, *p* = 0.038) ([Table IV](#t0004){ref-type="table"}). The mean length of hospitalization in patients who survived was significantly longer than in those who died (ischemic 15.8 ±14.1; 9.6 ±9.8 days; *p* \< 0.0001; hemorrhagic 25.3 ±19.0 vs. 14.3 ±15.1 days; *p* = 0.011). In patients with ischemic stroke in-hospital death occurred on the 10^th^ day of treatment and in hemorrhagic stroke patients on the 14^th^. 60.7% of ischemic stroke patients were discharged to home. Every fourth patient with ischemic stroke was transferred to another health care facility. The duration of hospitalization was similar among patients with ischemic stroke and with/without diabetes. Only one third of the patients with hemorrhagic stroke were discharged to home; the rest of patients were transferred to other health care facilities ([Table V](#t0005){ref-type="table"}).

###### 

Serum glucose at admission in regard to the presence of diabetes

  Parameter                                        Non-diabetic   Diabetic        Total   *P*-value                               
  --------------------------------------- -------- -------------- --------------- ------- ---------------- ------ --------------- --------------
  Serum glucose at admission \[mg/dl\]:                                                                                           
   Ischemic stroke                                 462            110.13 ±29.09   132     173.95 ±102.53   594    124.31 ±60.71   **\< 0.001**
   Hemorrhagic stroke                              112            117.43 ±10.34   12      158.08 ±56.30    124    121.36 ±43.56   **0.001**
  Serum glucose \[mg/dl\]:                                                                                                        
   Ischemic stroke                        \< 140   410            88.7            68      51.5             478    80.5            **\< 0.001**
  140--200                                43       9.3            26              19.7    69               11.6                   
  ≥ 200                                   9        1.9            38              28.8    47               7.9                    
   Hemorrhagic stroke                     \< 140   94             83.9            6       50.0             100    80.6            **0.014**
  140--200                                12       10.7           4               33.3    16               12.9                   
  ≥ 200                                   6        5.4            2               16.7    8                6.5                    

###### 

Survival and mortality of the studied group

  Parameter                                          Non-diabetic   Diabetic   Total   *P*-value                  
  -------------------- ----------------- ----------- -------------- ---------- ------- ----------- ------ ------- -------
  End of treatment     Ischemic stroke   Discharge   431            86.4       122     89.1        553    86.9    0.475
  Death                68                13.6        15             10.9       83      13.1                       
  Hemorrhagic stroke   Discharge         92          78.6           6          50.0    98          76.0   0.038   
  Death                25                21.4        6              50.0       31      24.0                       

###### 

Outcome of the studied groups

  Parameter                 Type of stroke       Total        Survived              Death                    *P-*value                               
  ------------------------- -------------------- ------------ --------------------- ------------------------ --------------- ------------ ---------- --------------
  Length of stay \[days\]   Ischemic stroke      637          15.0 ±13.8            553                      15.8 ±14.1      84           9.6 ±9.8   \< 0.001
  Hemorrhagic stroke        129                  22.7 ±18.7   98                    25.3 ±19.0               31              14.3 ±15.1   0.011      
  **Parameter**             **Type of stroke**   **Total**    **Ischemic stroke**   **Hemorrhagic stroke**   ***P*-value**                           
  ***N***                   **%**                ***N***      **%**                 ***N***                  **%**                                   
  End of treatment          Discharge            432          56.5                  387                      60.7            45           35.2       **\< 0.001**
  Transfer                  218                  28.5         166                   26.1                     52              40.6                    
  Death                     115                  15.0         84                    13.2                     31              24.2                    

Mean serum glucose levels at admission are given in [Table VI](#t0006){ref-type="table"}. The mean duration of hospitalization of patients with hemorrhagic stroke was significantly longer than that of patients with ischemic stroke (22.65 ±18.70 vs. 15.03 ±13.73; respectively *p* = 0.002). The duration of hospitalization was significantly longer in patients with hemorrhagic stroke and diabetes ([Table VII](#t0007){ref-type="table"}). The only correlation was observed between admission glucose and the length of hospitalization of patients with hemorrhagic stroke and diabetes (*r* = --0.74, *p* = 0.006) ([Table VIII](#t0008){ref-type="table"}). In multivariate analysis ([Table IX](#t0009){ref-type="table"}), the risk factors for outcome in patients with ischemic stroke and without diabetes were age (*p* \< 0.04; OR = 1.040), admission glucose level (*p* \< 0.001; OR = 1.021) and eGFR using the Modification of Diet in Renal Disease (MDRD) equation (*p* = 0.007; OR = 0.979), and in diabetics they were female gender (*p* = 0.022; OR = 6.610), admission glucose level (*p* = 0.010; OR = 1.007), and eGFR using the MDRD equation (*p* \< 0.001; OR = 0.937). In patients with hemorrhagic stroke and without diabetes the risk factors for outcome were age (*p* = 0.013; OR = 1.058) and admission glucose levels (*p* = 0.003; OR = 1.024). The study attempted to determine the admission glucose cut-off value for increased mortality. The predictive value of blood glucose level for mortality of ischemic stroke patients was estimated by receiver operating curve (ROC) analysis. The analysis was performed for diabetic and non-diabetic patients separately. In both cases, the area under the ROC curve (area under curve -- AUC) was significantly higher than 0.5, which indicated the predictive value of blood glucose level. The optimal cut-off value was determined as the point of the ROC curve less distant from the ideal point (100% sensitivity and 100% specificity). The admission glucose cut-off value in predicting death in patients with ischemic stroke and without diabetes was above 113.5 mg/dl (52.63% sensitivity and 70.69% specificity). However, for patients with diabetes the admission glucose cut-off value for increased mortality was much higher: 210.5 mg/dl (60% sensitivity, 76.92% specificity). Due to the low number of events the admission glucose cut-off value in predicting death in patients with hemorrhagic stroke was not determined.

###### 

Mean serum glucose at admission in relation to presence of diabetes and type of stroke

  Type of stroke                               Diabetes                                            
  ------------------------------- ------------ ---------------- ---------------- ----------------- ----------------
  Ischemic stroke                 Survived     406              107.58 ±24.955   117               165.6 ±97.384
  Death                           56           128.55 ±45.991   15               239.13 ±121.063   
  Whole group                     462          110.13 ±29.093   132              173.95 ±102.533   
  *P*-value (Mann-Whitney test)   **0.0005**   **0.002**                                           
  Hemorrhagic stroke              Survived     87               109.55 ±34.369   6                 119.67 ±14.123
  Death                           25           144.84 ±47.793   6                196.5 ±56.843     
  Whole group                     112          117.43 ±40.335   12               158.08 ±56.297    
  *P*-value (Mann-Whitney test)   **0.0001**   **0.004**                                           

###### 

Length of stay in relation to presence of diabetes

  Parameter                             Outcome    Length of stay \[days\]   *P*-value      
  ------------------------------------- ---------- ------------------------- -------------- --------------
  Ischemic stroke without diabetes      Survived   431                       16.01 ±15.10   **\< 0.001**
  Death                                 68         10.41 ±10.57                             
  Whole group                           499        15.25 ±14.68                             
  Ischemic stroke with diabetes         Survived   122                       15.27 ±9.74    **\< 0.001**
  Death                                 15         6.33 ±4.32                               
  Whole group                           137        14.29 ±9.70                              
  Hemorrhagic stroke without diabetes   Survived   92                        24.60 ±19.37   0.077
  Death                                 25         15.60 ±16.15                             
  Whole group                           117        22.68 ±19.03                             
  Hemorrhagic stroke with diabetes      Survived   6                         36.00 ±6.72    **\< 0.001**
  Death                                 6          8.83 ±8.16                               
  Whole group                           12         22.42 ±15.88                             

###### 

Non-parametric correlations between presence of diabetes and length of stay

  Type of stroke       Parameter   Diabetes    
  -------------------- ----------- ----------- --------
  Ischemic stroke      *r*         0.02        0.09
  *P*-value            0.717       0.289       
  Hemorrhagic stroke   *r*         --0.15      --0.77
  *P*-value            0.122       **0.006**   

###### 

Predictors of death in relation to presence of diabetes in stepwise logistic regression analysis (full model and elimination model)

  Type of stroke                        Parameter      Full model   Elimination model               
  ------------------------------------- -------------- ------------ ------------------- ----------- -------
  Ischemic stroke without diabetes      Age            0.096        1.033               **0.040**   1.040
  Gender (female vs. male)              0.201          0.628                                        
  Glucose at admission                  **\< 0.001**   1.021        **\< 0.001**        1.021       
  eGFR by MDRD                          **0.010**      0.980        **0.007**           0.979       
  Systolic blood pressure               0.077          0.987        0.081               0.987       
  Ischemic stroke with diabetes         Age            0.241        1.068                           
  Gender (female vs. male)              **0.012**      9.485        **0.022**           6.610       
  Glucose at admission                  **0.011**      1.007        **0.010**           1.007       
  eGFR by MDRD                          **0.001**      0.942        **\< 0.001**        0.937       
  Systolic blood pressure               0.155          0.970        0.095               0.966       
  Hemorrhagic stroke without diabetes   Age            **0.023**    1.057               **0.013**   1.058
  Gender (female vs. male)              0.451          1.602                                        
  Glucose at admission                  **0.008**      1.024        **0.003**           1.024       
  eGFR by MDRD                          0.530          0.993                                        

Discussion {#sec4}
==========

Our study demonstrated that hyperglycemia on admission is associated with worsened clinical outcome and increased risk of in-hospital death in ischemic and hemorrhagic stroke patients. Diabetes increased the risk of in-hospital death in hemorrhagic stroke patients, but not in ischemic stroke. Farrokhnia *et al.* \[[@cit0015]\] reported that the mean blood glucose concentration above 113 mg/dl predicted 30-day mortality in non-diabetic patients with stroke. However, for patients with diabetes, the value for such increased mortality was much higher at 185 mg/dl. In our work we also evaluated the admission glucose cut-off value for increased mortality. In patients with ischemic stroke and diabetes the cut-off value was 210.5 mg/dl, and in patients with ischemic stroke and without diabetes it was 113.5 mg/dl. This observation confirmed that a differential response to hyperglycemia existed between patients with and without diabetes. Several mechanisms may play a role in this finding. Patients with diabetes are more likely to receive insulin and oral hypoglycemic treatment; however, all hypoglycemic drugs may influence glucometabolic health and endovascular inflammation \[[@cit0016]\]. In our study, patients with diabetes (30.7% with ischemic and 66.7% with hemorrhagic stroke) received insulin treatment. Furthermore, patients with diabetes may have reduced metabolic effects of hyperglycemia through chronic exposure to the evaluated glucose level. Then again, patients with diabetes have a higher glucose level that increased in-hospital mortality \[[@cit0003], [@cit0015]\]. Many factors have been identified through which hyperglycemia could increase cerebral damage in ischemic stroke \[[@cit0013]\]. Magnetic resonance imaging (MRI) has demonstrated that in patients with acute perfusion diffusion mismatch within 24 h of stroke onset, hyperglycemia correlated with reduced salvage of mismatch tissue from infarction, greater final size and worse outcome \[[@cit0013], [@cit0017]--[@cit0019]\]. Moreover, admission hyperglycemia impaired recanalization in patients with acute ischemic stroke, which may cause a worse clinical outcome after thrombolytic therapy \[[@cit0017], [@cit0020]\]. Decrease in perfusion in ischemic stroke has been associated with disturbances in coagulation and fibrinolysis and changes in blood rheology (increased blood viscosity, erythrocyte reduced susceptibility to deformation, increased tendency of red blood cells to form microaggregates) \[[@cit0013], [@cit0021]--[@cit0023]\]. Exposure of brain tissue to excessive levels of glucose resulted in disruption of the blood-brain barrier, anaerobic glycolysis, lactate accumulation, tissue acidosis, the formation of free radicals, release of excitatory neurotransmitters and calcium influx into the cell \[[@cit0005], [@cit0022]--[@cit0024]\]. Poorly controlled hyperglycemia reduces cerebral blood flow and oxygenation of tissues, and increases intracranial pressure, cerebral edema and neuronal death \[[@cit0014], [@cit0024]--[@cit0026]\]. These mechanisms, which are more severe in patients with diabetes and hemorrhagic stroke, perhaps increase mortality in hemorrhagic stroke, as in our work. Most of the studies have focused on the evaluation of hyperglycemia on admission and its impact on outcome and mortality in ischemic or hemorrhagic stroke \[[@cit0003], [@cit0008]--[@cit0010], [@cit0014]\]. In our work, we analyzed patients with ischemic and hemorrhagic stroke and with and without diabetes. Many studies have shown that hyperglycemia worsens the prognosis of ischemic stroke \[[@cit0003], [@cit0008]--[@cit0010]\]. Analysis of the GLIAS (GLycemia In Acute Stroke) study showed that persistent hyperglycemia above 155 mg/dl is commonly observed in patients with ischemic stroke and is associated with poorer outcome \[[@cit0027]\]. Hu *et al.* \[[@cit0003]\] found a significant association between initial glucose level and mortality in patients with ischemic stroke and without diabetes. In our study diabetes did not increase the risk of mortality in ischemic stroke. These differences between groups of patients with and without diabetes and ischemic stroke is likely to result in different glucose cut-off values for increased mortality. Appelboom *et al.* \[[@cit0014]\] confirmed the relationship between admission glucose and mortality in patients with spontaneous intracerebral hemorrhage and severity of intraventricular extension. Other studies have also observed that hyperglycemia in patients with hemorrhagic stroke is an independent risk factor for mortality and poor clinical outcome and may affect the increase in the size of hematoma \[[@cit0028]--[@cit0031]\]. In addition, altered glucose metabolism may be due to inflammatory cell activation, as suggested by Tapia-Pérez *et al.* \[[@cit0032]\] on the basis of a relatively small retrospective study. Also serum lipids and kidney function may play a role in complications of diabetes \[[@cit0033]\]. In addition, increased serum level of soluble CXCL16 was independently associated with atherosclerotic ischemic stroke, as reported recently \[[@cit0034]\].

In our study diabetes was a risk factor for death in hemorrhagic stroke, in contrast to the study of Wang *et al.* \[[@cit0035]\]. They suggested that diabetes in Han Chinese patients with hemorrhagic stroke was not associated with increased mortality or functional outcome. It may be due to the genetic predisposition. Unlike in Caucasians, the minor allele C of rs11206510 was associated with increased LDL cholesterol levels in the Chinese Han population and conferred a risk of early-onset coronary artery disease and a significant risk of ischemic stroke \[[@cit0036]\]. Similarly, allele 936C of VEGF may serve as a genetic marker susceptible to diabetic neuropathy in Han Chinese, while allele 936T may be a protective genetic marker of it \[[@cit0037]\]. However, in the population of Southern China diabetes together with hypertension and hyperlipidemia was more prevalent in patients with lacunar infarction \[[@cit0038]\]. On the other hand, as decreased exercise capacity is an independent risk factor for major adverse cardiovascular events (MACE) in diabetes \[[@cit0039]\] as well as lower limb ischemia \[[@cit0040]\], it is also relevant for stroke. In recent studies, mainly registry or cohort studies, underlying the role of diabetes as a risk factor for death in stroke, the type of stroke is not elucidated \[[@cit0041]--[@cit0043]\], while in our relatively large sample we defined the type of stroke as Bhalla *et al.* \[[@cit0044]\] did in the South London Stroke Register. However, the Londoners with diabetes had poorer survival in ischemic stroke, while in general hemorrhagic stroke was associated with worse outcome up to 5 years after the event. In our study we focused on the in-hospital mortality and length of stay as well as the end of treatment (discharge or transfer to other health care facility). The duration of hospitalization was similar among patients with ischemic stroke and with/without diabetes. The length of hospital stay was significantly longer in patients with hemorrhagic stroke and diabetes. About 30% of patients with hemorrhagic stroke were discharged to home; the rest of the patients were transferred to other health care facilities. Extending the duration of hospitalization of patients with hemorrhagic stroke up to 10 days is associated with increased costs of treatment. Treatment of hyperglycemia during hospitalization improves outcomes, reduces long-term disability and shortens duration of hospitalization. Then, hospitals have greater chances of achieving significant cost savings. Lower admission glucose level impacts the mortality in non-diabetic patients compared to patients with diabetes. We would like to stress that it is very important to control the level of glucose during hospitalization in all patients with stroke (with and without diabetes). In addition, not only the presence of diabetes but also, or even more importantly, hyperglycemia is a poor predictor of outcomes in both types of stroke. Kidney function, in particular in ischemic stroke, also has a great impact on the outcome.

In conclusion, hyperglycemia on admission is associated with worsened clinical outcome and increased risk of in-hospital death in ischemic and hemorrhagic stroke patients. Diabetes increased the risk of in-hospital death in hemorrhagic stroke patients, but not in ischemic stroke. The admission glucose cut-off value in predicting death in patients with ischemic stroke and diabetes was much higher than in non-diabetic patients. The duration of hospitalization of patients with hemorrhagic stroke and diabetes who died was longer compared to non-diabetic patients. Approximately 26.1% of patients with ischemic stroke were transferred to another health care facility to continue treatment or rehabilitation, compared to 40.6% of patients with hemorrhagic stroke.

Conflict of interest
====================

The authors declare no conflict of interest.
